Lung cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Male or female patients aged between 18 and 80. 2. Patients diagnosed as requiring lobectomy, including but not limited to those with lung cancer, benign lung tumors or other lung diseases that require surgical treatment. 3. Pulmonary function assessment: the results of the pulmonary function test show that the patient is tolerant to the surgery 4.The results of the blood routine test show that all the patient's blood indicators are within the normal range 5. Normal liver function 6.The results of the electrocardiogram (ECG) and echocardiogram tests show that the heart function is positive,there are often or only mild abnormalities, and no history of serious heart disease. 7. The patient is capable and willing to have 150ml of venous blood drawn one day before the operation for the preparation of platelet-rich plasma (PRP). 8. The patient voluntarily participated in this study and has thoroughly understood the study content, process, possible risks and benefits. 9. No serious mental or psychological disorders, and able to cooperate to complete the entire research process.
Exclusion criteria
Exclusion criteria: 1. Patients with severe coagulation dysfunction; 2. Patients allergic to blood products; 3. Patients who have used other drugs or treatments that may affect postoperative healing before the operation; 4. Situations where other researchers consider it inappropriate to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative thoracic drainage volume; The incidence of postoperative air leakage; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative hospital stay; | — |
Countries
China
Contacts
The Affiliated Hospital of Qingdao University